Clinical Study
Cardiac Troponin Elevation Predicts Mortality in Patients Undergoing Orthotopic Liver Transplantation
Table 2
Comparisons of types of liver disease.
| | All patients | Troponin | Negative | Intermediate | Elevated |
| Primary liver disease () | 78 | 42 | 28 | 8 | Alcohol | 10 (12.8%) | 5 (11.9%) | 2 (7.1%) | 3 (37.5%) | Hepatitis C | 30 (38.5%) | 19 (45.2%) | 9 (32.1%) | 2 (25.0%) | NASH | 11 (14.1%) | 5 (11.9%) | 4 (14.3%) | 2 (25.0%) | PBC | 5 (6.4%) | 2 (4.8%) | 3 (10.7%) | 0 (0.0%) | PSC | 5 (6.4%) | 4 (9.5%) | 1 (3.6%) | 0 (0.0%) | Acetaminophen | 1 (1.3%) | 1 (2.4%) | 0 (0.0%) | 0 (0.0%) | Cryptogenic | 13 (3.9%) | 6 (14.3%) | 6 (21.4%) | 1 (12.5%) | Polycystic | 2 (2.6%) | 0 (0.0%) | 2 (7.1%) | 0 (0.0%) | Autoimmune | 1 (1.3%) | 0 (0.0%) | 1 (3.6%) | 0 (0.0%) | Secondary liver disease () | 19 (24.4%) | 13 (31.0%) | 5 (17.9%) | 1 (12.5%) | Alcohol | 3 (15.8%) | 2 (15.4%) | 1 (20.0%) | 0 (0.0%) | Hepatitis C | 1 (5.3%) | 0 (0.0%) | 1 (20.0%) | 0 (0.0%) | HC | 15 (78.9%) | 11 (8.5%) | 3 (60.0%) | 1 (100.0%) |
|
|
NASH: nonalcoholic steatohepatitis; PBC: primary biliary cirrhosis; PSC: primary sclerosing cholangitis; acetaminophen: acetaminophen toxicity; HC: hepatocellular carcinoma.
|